Erika Raines, NP
Nurse Practitioner · Aiken, SCNPI 1942783147
Payments from drug & device makers
Across 90 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$321
- Novo Nordisk$246
- AbbVie$165
- Takeda Pharmaceuticals U.S.A., Inc.$147
- Novartis$96
- Boehringer Ingelheim$75
- plus $482 from 14 others
What the payments were for
- Food & beverage$1,532100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 15 | $321 |
| Novo Nordisk | 17 | $246 |
| AbbVie | 8 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $147 |
| Novartis | 5 | $96 |
| Boehringer Ingelheim | 5 | $75 |
| AstraZeneca | 5 | $71 |
| Pfizer | 4 | $67 |
| GSK | 4 | $58 |
| Amgen | 3 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Exact Sciences | 2 | $32 |
| Abbott | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Irhythm Technologies, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$1,532 in reported general payments places this provider in the 80th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 82 | $108,520 |
| JardianceEmpagliflozin | 78 | $70,008 |
| EliquisApixaban | 58 | $53,316 |
| OzempicSemaglutide | 32 | $40,981 |
| Repatha SureclickEvolocumab | 21 | $22,779 |
| RybelsusSemaglutide | 19 | $19,568 |
| JanuviaSitagliptin Phosphate | 21 | $16,801 |
| LinzessLinaclotide | 21 | $16,114 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $11,857 |
| Lagevrio (Eua)Molnupiravir | 14 | $6,845 |
| DexilantDexlansoprazole | 11 | $3,186 |
| Icosapent Ethyl | 12 | $3,115 |
| Gabapentin | 97 | $1,611 |
| Omeprazole | 80 | $1,359 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $1,291 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $321 | $108,52082 claims |
| Boehringer IngelheimJardiance | $75 | $70,00878 claims |
| Novo NordiskOzempic, Rybelsus | $246 | $60,54951 claims |
| PfizerEliquis | $67 | $53,31658 claims |
| MerckJanuvia, Lagevrio (Eua) | $15 | $23,64635 claims |
| AbbVieLinzess, Synthroid | $165 | $17,21032 claims |
| GSKTrelegy Ellipta | $58 | $11,85719 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Dexilant | $147 | $3,18611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Aiken
- Stacey Bulfinch IdicaAiken$17K
- Jenna DavisColumbia$202K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Colleen BoydSummerville$21K
- Mae BurtonGreenville$21K
- Melissa BramanteColumbia$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.